Rescheduling: Progress or Power Move?

This content is protected against AI scraping.

President Trump’s decision to replace Attorney General Pam Bondi with his former lawyer, Todd Blanche, is unlikely to derail the push to move marijuana to Schedule III. Industry insiders report that Blanche is already well-versed in the transition, with some expecting movement on a final rule within the next 30 to 60 days. While the leadership has changed, the administration’s directive to expedite rescheduling remains a priority.

Despite this continuity, the shift to Schedule III is not a total victory for the cannabis industry. It does not federally legalize marijuana, facilitate interstate commerce, or guarantee criminal justice reform. Instead, it places cannabis under tighter medical regulations and federal oversight, likely triggering immediate legal challenges from prohibitionist groups that could delay any actual tax relief or business benefits.

Ultimately, Bondi’s exit changes the messenger but not the message. The process remains a politically charged, medical-focused project that leaves the industry in a state of “core uncertainty.” Even if rescheduling happens quickly under Blanche, the real-world impact may be stalled by litigation, leaving the question of who truly benefits from these reforms unanswered.

This is a summary. Read the original article here.
Original article written by Javier Hasse. Published on April 3, 2026 by HighTimes.